A ctivity of tissue renin-angiotensin-aldosterone systems (RAAS), particularly within the kidney, appears to have importance beyond what is apparent from measures of the circulating RAAS in relation to hypertension, 1 diabetic and other nephropathy, 2, 3 congestive heart failure, 4 and stroke. 5 Results from our group provide clear evidence of increased renovascular tone supported by higher intrarenal angiotensin II (Ang II) that was not reflected by differences in plasma aldosterone, Ang II, or plasma renin activity. 6 Increases in renal plasma flow varied widely between individuals after renin or ACE inhibition, but responses to the 2 drugs were highly correlated. 3 A more indirect measure of intrarenal RAAS activity, change in renal plasma flow after infused Ang II, also correlated with the response to pharmacological RAAS inhibition. 7 These findings are consistent with the hypothesis that high baseline intrarenal Ang II predicts both a greater increase in renal plasma flow in response to a RAAS-blocking drug and a blunted response (less of a decrease) to infused Ang II, presumably because of downregulation of renovascular Ang II type 1 (AT 1 ) receptors in the face of high tissue Ang II. With its apparent strong familial component, renovascular response to exogenous Ang II infusion during a high-salt diet (when responses are normally maximal) is an attractive intermediate phenotype in the study of the genetics of human hypertension. 8, 9 For similar reasons, adrenal responses during a low-salt diet 8, 9 and atrial natriuretic peptide 10 responses to infused Ang II have been suggested as intermediate phenotypes of considerable interest.
One of our major goals has been to identify genetic contributions to the expression of these intermediate phenotypes. Initial candidate genes of interest have been elements of the RAAS, particularly angiotensinogen (AGT), given the generally positive linkage 11 and association 12 of certain AGT polymorphisms with hypertension. Examination of genotypic association, however, is complicated by the recognition that additional factors blunt renal or adrenal responses to infused Ang II, including male sex, 13 black race, 14 diabetes, 15 acute hyperglycemia, 16 obesity, 17 and insulin resistance. 18 We considered these issues in a previous multivariate analysis and found an independent association with the AGT235T polymorphism and reduced renal vasoconstriction in response to infused Ang II. 17 That study was limited by inclusion of few hypertensive subjects (most subjects were normotensive rel-atives of hypertensives) and performance of infusions only during a high-salt diet.
The completion of Ang II infusions in an unprecedented number of hypertensive subjects studied during both carefully controlled high-and low-salt diets afforded us the opportunity to examine genotypic effects on adrenal and renal vascular responses to infused Ang II. Specific new questions include whether AGT genotype is associated with both renal and adrenal response to Ang II and whether influences from other factors differentially affect the genotypic associations.
Methods

Subjects and Protocol
Subjects in this report were studied by the international HyperPath (Hypertensive Pathotype) group. 19 Included in this report are a total of 190 hypertensive patients with AGT genotypes who completed renal plasma flow studies on a high-salt diet and plasma aldosterone measurements on a low-salt diet. Patients were studied at the General Clinical Research Centers (GCRCs) of the Brigham and Women's Hospital in Boston (nϭ101) or at the University of Utah Medical Center in Salt Lake City (nϭ89). Details of these protocols have been reported previously. 17, 19 Hypertension diagnosis before age 60 years in the patient and Ն1 other sibling and current age 18 to 65 years were the major inclusion criteria. Relatively severe hypertension was required to be present in Ն1 sibling, defined as diastolic blood pressure Ն100 mm Hg off medication on Ն3 occasions, diastolic blood pressure Ն90 mm Hg while taking Ն1 antihypertensive medication on Ն3 occasions, or treatment with Ն2 antihypertensive medications. Less severely affected siblings had to have a diastolic blood pressure of Ն90 mm Hg off medication on Ն3 occasions or diastolic blood pressure of Ն80 mm Hg on 1 antihypertensive medication on Ն3 occasions. Exclusion criteria included substantial obesity (body mass index [BMI] Ͼ33 kg/m 2 for men, Ͼ31 kg/m 2 for women), diabetes mellitus (use of hypoglycemic drugs or serum glucose Ͼ126 mg/dL), renal insufficiency (serum creatinine Ͼ1.9 mg/dL), secondary forms of hypertension (based on history, physical examination, and multichannel serum chemistry screening), or any other significant medical problem. All subjects had a screening history and physical and laboratory examinations. Antihypertensive medications, if used, were withdrawn gradually such that all subjects were off medication for Ն2 weeks before the Ang II infusion studies. ACE inhibitors and angiotensin receptor blockers were discontinued 3 months before the study. The Institutional Review Board of each center approved the study, and all patients gave informed written consent before enrollment. There were 80 patients studied with no other sibling included, 98 patients from affected sibling pairs (49 sibships), and 12 studied from affected trios (4 sibships).
All subjects received high-salt (Ն200 mmol sodium/d) and lowsalt (10 mmol sodium/d) foods from the GCRC research kitchen to be consumed as outpatients. Subjects were admitted to the GCRC the night before studies. They received Ang II infusions at 3 ng · kg Ϫ1 · min Ϫ1 on day 7 of high-and low-salt diets after overnight bed rest in the GCRC. Effective renal plasma flow (as p-aminohippuric acid clearance) was calculated from steady-state plasma p-aminohippuric acid concentrations at baseline and at the end of the Ang II infusion period as previously described. 17 Effective renal plasma flow was normalized to a BSA of 1.73 m ϫ0.007184, where BSA is body surface area in square meters, W is weight in kilograms, and H is height in centimeters. Baseline blood pressure for this study refers to the mean of 3 consecutive readings (by Dinamap) separated by 5 minutes each measured at bed rest on the morning of the high-or low-salt studies in the GCRC obtained 30 minutes before initiation of the Ang II infusion.
Details of all laboratory assays and genotyping have been described previously. 17, 19, 20 Low-renin patients were defined as having a plasma renin activity of Ͻ2.4 ng Ang I · mL Ϫ1 · h Ϫ1 after 2 hours of upright posture when in balance on a 10 mmol/d sodium diet as in previous studies. 19 The posture study was performed the day before hospital admission for the Ang II infusion during the low-salt diet. Plasma renin activity was measured in blood drawn at baseline just before the Ang II infusions on both high-and low-salt diet after patients had remained supine overnight in the GCRC. Protocols were carefully standardized at each site through start-up and periodic visits between clinic sites, regular conference calls, and use of common written protocols and clinical data collection forms. All assays were performed at a central laboratory. Importantly, there were no consistent differences in key performance variables between the centers, including 24-hour urinary sodium excretions, renal plasma flow and aldosterone responses to infused Ang II, or blood pressure responses except for systolic blood pressure response on the low-salt diet (14.8Ϯ11.9 mm Hg, Boston; 19.8Ϯ13.1 mm Hg, Salt Lake City; Pϭ0.008).
Statistical Analysis
All statistical analyses were performed with the SAS 8.0 statistical analysis package for the PC (SAS Institute Inc). The primary response variables were examined by comparing the lowest tertile with the upper 2 tertiles of change in response to Ang II infusion. This approach does not require any assumption about distribution of the outcome variable or the nature of its relationship to dependent variables. It allows us to focus on effects that lower response (the primary response of interest) without giving undue weight to factors that may be associated with large responses. Indeed, entirely different genetic or other correlates may be associated with increased as opposed to blunted response. Generalized estimating equations (PROC GENMOD using family number as the repeated variable) were used to correct for potential inflation of significance estimates caused by inclusion of family members (with potential nonindependence of observations). Previous studies suggest that this is a conservative method to correct for potential inflation of probability value and that for most situations, no special method of adjustment because of family dependencies is, in fact, necessary. 21 
Results
The major phenotypes of interest in this study were renal vascular response to infused Ang II on a high-salt diet and adrenal response to infused Ang II on a low-salt diet. Reduced renal vascular response was defined as the lowest tertile of change for renal plasma flow on a high-salt diet (decrement Ͻ71 mL/min for this population). Reduced adrenal response was defined as the lowest tertile of change for plasma aldosterone (a Ͻ416 pmol/L [15 ng/dL] increment in plasma aldosterone). Clinical characteristics, renal plasma flow measurements, plasma aldosterone levels, and AGT genotypes are compared in those with reduced (lowest tertile) or normal (upper 2 tertiles) renal and adrenal responses in Table 1 .
As shown in Table 1 , AGT genotype was the only factor tested that consistently associated with both a reduced renal vasculature and reduced adrenal response to Ang II infusion. Older age, higher BMI, more severe hypertension, and lower baseline renal plasma flow associated with a smaller decrement of renal plasma flow on a high-salt diet. Other than AGT genotype, male sex, black race, and higher urinary sodium (borderline) were associated with a smaller adrenal response. There was no relationship between serum potassium concentrations during the high-or low-salt diet and either adrenal or renovascular responses to infused Ang II.
Association of the Ϫ6A allele with renal or adrenal unresponsiveness (and concordance for both) was tested further in several subgroups (Figure 1 ). In general, odds ratios were in the direction expected and showed little heterogeneity. Too few blacks were tested to confirm AGT genotypic associations separately. The association of AGT genotype with reduced renal or adrenal responses after simultaneous control for other factors was confirmed in multiple logistic regression ( Table 2 ). All of the factors listed in Table 2 were found to be independently associated with renal or adrenal response. As suggested by Table 1 and confirmed in the logistic regression analysis, the renal phenotype was influenced by more factors, the most significant being baseline renal plasma flow and BMI. Importantly, even after adjustment for other correlates, AGT genotype remained independently associated with both renal and adrenal response. AGT genotype was not significantly associated with any of the other factors listed in Table 1 except race. Multiple logistic regression stratified by race (to avoid colinearity issues between race and genotype) yielded results similar to those shown in Figure 1 .
We also examined the association of AGT genotype with phenotype defined as concordant unresponsive, concordant responsive, or discordant as shown in Figure 2 . The 2 value for AGT association was 18.6, with Pϭ0.0010 (2 degrees of freedom). When patients were defined as concordantly responsive or unresponsive by both criteria, AGT genotype remained highly and independently associated ( Figure 1 , Table 2 ).
The discordant patients were then examined separately to provide insights as to why some patients would have only renal or adrenal unresponsiveness. The same variables as in Table 1 were examined for differences between these 2 discordant groups. As shown in Table 3 , patients with reduced renal but not adrenal responses had significantly greater BMI and diastolic blood pressure, but lower baseline renal plasma flow. The other differences shown in Table 3 were expected, on the basis of the respective definitions of the phenotypes. When age, sex, BMI, baseline diastolic blood pressure, serum creatinine, creatinine clearance, baseline renal plasma flow, and AGT genotype were entered into multiple logistic regression with backward stepping, only BMI (Pϭ0.03) and baseline renal plasma flow (Pϭ0.003) remained in the model. In discriminant function analysis, BMI and baseline renal plasma flow correctly classified 76% of the discordant patients (Wilks 0.671, PՅ0.0001 for both BMI and baseline renal plasma flow). Thus, much of the difference in phenotypic expression could be explained by greater BMI and lower baseline renal plasma flow in those with a reduced renal vascular response to Ang II but a normal adrenal response.
Discussion
We have found a strong association between reduced renal vascular and adrenal responses to infused Ang II and the AGT Ϫ6A genotype among a large group of hypertensive patients. This is the first report of such an association with assessment of both renal vascular (on high salt) and adrenal (on low salt) phenotypes in all subjects. The strong association of higher BMI and lower baseline renal plasma flow with blunted renal vascular response but not blunted adrenal response was responsible for much of the difference in phenotypic expression between individuals not explained by genotype and provided additional insights into the complexity of these phenotypes. BP indicates blood pressure; RPF, renal plasma flow. Backward stepping was used (Pϭ0.05 to keep) with the following initial independent variables: age, sex, BMI, urinary sodium on low-salt diet, baseline diastolic BP on high-salt diet, baseline RPF on high-salt diet, and AGT Ϫ6 genotype. AGT Ϫ6 genotype was coded as 1, GG; 2, GA; and 3, AA. Generalized estimating equations using family number as a repeated variable were used to determine the P value shown.
*Includes 27 concordant lowest-tertile responders and 90 concordant more responsive patients. AGT genotype (%) in hypertensive patients categorized as concordant unresponsive to infused Ang II (by both renal vascular and adrenal criteria), concordant responsive, and discordant patients (either unresponsive by renal vascular criteria but not adrenal criteria or vice versa). Excess of AGT Ϫ6AA genotypes among unresponsive patients is readily apparent. Association was significant, with 2 ϭ18.6 and Pϭ0.0010.
How might variants of the AGT gene promote blunted renal and adrenal responses to infused Ang II, and how might such changes be related to hypertension? For the renal response, we may hypothesize that an increase in intrarenal production of angiotensinogen associated with the AGT Ϫ6A variant would be expected to lead to increased tissue Ang II, 1 downregulation of AT 1 receptors (which are normally upregulated during a high-salt diet), and decreased renovascular response to infused Ang II. These changes would be expected to lead to modest changes in renal hemodynamics and salt handling favoring hypertension. Data in support of this hypothesis are indirect and not without some negative findings or controversy. However, a recent meta-analysis of 69 association studies with 27 906 subjects concluded that the AGT 235TT genotype conferred 31% greater risk for hypertension (Pϭ0.001), whereas those with the MT genotype had 11% greater risk (Pϭ0.03). 12 The AGT 235T polymorphism, although without any apparent functional significance itself, is in almost complete linkage disequilibrium with the Ϫ6A variant in the promoter region of AGT, which, in expression studies, was found to result in an increase in function compared with the Ϫ6G allele (hence the use of this variant in the present study). 22 Potentially relevant are findings in transgenic animal models that suggest a dose-dependent effect of renal angiotensinogen production on hypertension development. 1, 23 Several groups have reported other vascular disease associations with the AGT Ϫ6A (or 235T) variant, including increased left ventricular mass index, 24 brain infarctions, 25 and more rapid progression of immunoglobulin A nephropathy. 26, 27 One group 28 reported more rapid progression to end-stage renal disease in diabetics with the 235T variant, and another did not. 29 These and the present findings would suggest that effects caused by common AGT gene variants are likely to be modest in absolute terms, even when statistically apparent.
Explaining the blunted adrenal response in those with the AGT Ϫ6A variant may be less straightforward. In rats and mice, increased exposure to Ang II, including low-salt diet, actually upregulated both AT 1a and AT 1b receptors in the adrenal glomerulosa. 30 Other mammals have a single AT 1 receptor gene, which appears to undergo ligand-mediated downregulation in the adrenal, similar to the response in vascular and other smooth muscle cells. 31 In nonrodent mammals, virtually all of the increased sensitivity of adrenal aldosterone production to Ang II during a low-salt diet appears to be mediated by increased activity of enzymes in the synthetic pathway of aldosterone or other postreceptor effects, effects that are highly sensitive to salt balance. 32 Therefore, blunted adrenal response to infused Ang II in subjects with AGT Ϫ6A may reflect increased local RAAS activity and downregulation of AT 1 receptors and/or other factors that increase salt balance (including renal effects). The major effects of BMI and baseline renal plasma flow are consistent with our previous observations. 17 Recently, renal norepinephrine spillover was shown to be increased in both normotensive and hypertensive obese subjects. 33 Others also have reported interactions between body fat, blood pressure, and AGT genotype. 34 The lack of sympathetic nervous system effects on adrenal aldosterone production may explain the absence of an association between BMI and adrenal response. Although multiple factors affected renal vascular response, AGT genotype and sex were associated primarily with adrenal response in our study. The effect of race could not be statistically separated from the genotypic effect for the adrenal response. We therefore cannot exclude an additional, independent effect of black race on adrenal response. The powerful effect of sex on adrenal response has been reported previously. 13 In previous studies in our group, among 18 mostly male hypertensives, age 18 to 45 years, renal (on high salt) and adrenal (on low salt) responses to infused Ang II appeared highly correlated. 35 In the present series, just 42.2% of patients in the lower tertile of renal plasma flow decrement also had lower-tertile aldosterone increment (odds ratio 1.82, Pϭ0.059). The wider ranges in age, blood pressure, baseline renal vascular blood flow, and BMI and inclusion of 2 racial groups in the present study may explain the blurring of expected correlation between renal and adrenal responses to infused Ang II, as illustrated in Figure 3 . Examining the correlation in the subgroup with lower BMI (42 patients had BMI Ͻ25), 15 subjects had lower-tertile adrenal responses, but just 5 had lower-tertile renal responses to infused Ang II; 4 of these 5 also had lower-tertile adrenal responses (odds ratio 9.5, Pϭ0.028). Thus, higher BMI appeared to have been a major factor obscuring the expected correlation between renal and adrenal responses.
In conclusion, we have observed a significant association between AGT genotype and response to infused Ang II in hypertensive subjects on both high-and low-salt diets. The renal findings are consistent with the hypothesis that the AGT Ϫ6A genotype results in a modest increase in local Ang II production, leading to downregulation of AT 1 receptors and relative insensitivity to infused, exogenous Ang II. The basis for the adrenal findings may be more complex. Our findings indicate that phenotypic expression of genetic variation can be influenced by factors such as race, sex, obesity, and severity of hypertension but not necessarily equivalently in all target tissues. AGT was significantly associated with both renal and adrenal responses to infused Ang II. Strong association of sex only with adrenal response, race with adrenal response and AGT genotype, and equally strong associations of BMI, baseline renal plasma flow, and diastolic blood pressure only with renal response, however, essentially obliterated expected direct association between adrenal and renovascular response.
